Search

Your search keyword '"Lygirou V"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Lygirou V" Remove constraint Author: "Lygirou V"
49 results on '"Lygirou V"'

Search Results

1. Identification of markers for prostate cancer progression and aggressiveness through proteomic analysis of FFPE tissue samples

2. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

3. Proteome-based classification of Nonmuscle Invasive Bladder Cancer

4. A novel pipeline for drug repurposing for bladder cancer based on patients’ omics signatures

5. Proteomics Analysis of Formalin Fixed Paraffin Embedded Tissues in the Investigation of Prostate Cancer

7. High resolution analysis of the intracellular proteome of cervical cancer cell lines unveils novel regulators of cervical carcinogenesis

8. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

10. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

11. Proteome-based classification of non-muscle invasive bladder cancer

13. Cervical cancer cell line secretome highlights the roles of transforming growth factor-beta-induced protein ig-h3, peroxiredoxin-2, and NRF2 on cervical carcinogenesis

14. Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention

15. Proteomic analysis of normal and cancer cervical cell lines reveals deregulation of cytoskeleton-associated proteins

16. Effect of Heme Oxygenase-1 Deficiency on Glomerular Proteomics

17. Analytical performance of ELISA assays in Urine: One more bottleneck towards biomarker validation and clinical implementation

18. Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models

21. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

22. Tear Proteomics in Children and Adolescents with Type 1 Diabetes: A Promising Approach to Biomarker Identification of Diabetes Pathogenesis and Complications.

23. Investigation of the human-gut-kidney axis by fecal proteomics, highlights molecular mechanisms affected in CKD.

24. Ferroptosis-protective membrane domains in quiescence.

25. Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy.

26. Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non-responders' tumor tissue.

27. Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness.

28. Plasma Proteomics in Healthy Subjects with Differences in Tissue Glucocorticoid Sensitivity Identifies A Novel Proteomic Signature.

29. Urine peptidome analysis in cardiorenal syndrome reflects molecular processes.

30. A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients' Omics Signatures.

31. Proteomics Analysis of Formalin Fixed Paraffin Embedded Tissues in the Investigation of Prostate Cancer.

32. Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma.

33. Proteome-based classification of Nonmuscle Invasive Bladder Cancer.

34. High resolution analysis of the intracellular proteome of cervical cancer cell lines unveils novel regulators of cervical carcinogenesis.

35. Implications of the mitochondrial interactome of mammalian thioredoxin 2 for normal cellular function and disease.

36. Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment.

37. Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder Cancer.

38. Membrane proteomics of cervical cancer cell lines reveal insights on the process of cervical carcinogenesis.

39. Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease.

40. Novel structural approaches concerning HPV proteins: Insight into targeted therapies for cervical cancer (Review).

41. High Resolution Proteomic Analysis of the Cervical Cancer Cell Lines Secretome Documents Deregulation of Multiple Proteases.

42. Proteomic Analysis of Normal and Cancer Cervical Cell Lines Reveals Deregulation of Cytoskeleton-associated Proteins.

43. Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.

44. Proteomics in cardiovascular disease: recent progress and clinical implication and implementation.

45. Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.

46. Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models.

47. Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation.

48. Effect of Heme Oxygenase-1 Deficiency on Glomerular Proteomics.

49. Biological sample collection for clinical proteomics: existing SOPs.

Catalog

Books, media, physical & digital resources